External Pacemakers Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC648

Introduction

External pacemaker is an artificial medical device, also known as cardiac rhythm management device that generates low-energy electrical impulses to regulate abnormal heart rhythm. The external pacemakers are temporary pacemaking devices that are used to fulfill short-term demand indicated for therapeutic, prophylactic or diagnostic purposes. The major factors driving the growth of market includes technological development in external pacemakers and rising incidences of cardiovascular disorders globally.

Market Dynamics

The increase in adoption of non-invasive ultrasound-based pacemakers as an alternative to conventional pacemakers that offer pacing accuracy and easy parameter retrieval for the treatment of heart related issues have led to the growth of external pacemakers market globally. Growing ambulatory surgery services, rising healthcare expenditure, supportive government initiatives propel the growth of external pacemakers market globally. The major challenges include high cost of external pacemaker, lack of consumer awareness towards cardiovascular diseases in developing countries and presence of alternate treatments such as cardiac ablation-catheters and cardioverter defibrillators.

Market Classification and Overview

The external pacemakers market is bifurcated on the basis of type, application, end use industry, and geography. The different types of external pacemakers include single chamber temporary pacemaker, dual chamber temporary pacemaker, and triple chamber temporary pacemaker among others. Single chamber temporary pacemaker is the largest and most mature market as it caters to almost every type of application. Dual chamber temporary pacemaker is the fastest growing market owing to its longevity, and ability to adapt to the technological advancements in medical sector. Based on application, the market is segmented into arrhythmia, cardiac perforation, and local trauma among others. Arrhythmia is the largest application segment for external pacemakers market. The dual chamber temporary pacemaker is majorly preferred for atrial arrhythmia owing to its ability to ensure continuous monitoring of heart, and help enable appropriate therapy to the patient. Based on end use industry, the market is further segmented into healthcare and others. Healthcare dominates the global external pacemakers market globally. The growing demand for short-term pacemakers from hospitals, cardiac care centers and ambulatory surgical centers among others fuel the growth of external pacemakers in the healthcare industry.

Regional Overview

The market for external pacemakers is segmented into regions such as North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America was the major contributors to the growth of external pacemakers market in 2015. Europe was the second biggest market followed by Asia-Pacific. The market for external pacemakers in Asia-Pacific is further projected to witness highest growth in coming years owing to the increasing old age population, growth in the healthcare sector, and increasing R&D investments. The North America market is likely to grow at a significant rate owing to the growing number of geriatric population that has increased the demand for external pacemakers in the region.

Report Coverage

Market

External Pacemakers Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Application, End-Use Industry, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

Medtronic, Abbott, Boston Scientific, Biotronik, Oscor, Galix Biomedical Instrumentation, Sorin Group, Braile Biomedica, Osypka Medical, and Shree Pacetronix are the key players in the external pacemakers market. These players involved have adopted the strategies including mergers and acquisitions with local as well as established players.

Market Segmentation

Market By Type

  • Single Chamber Temporary Pacemaker
  • Dual Chamber Temporary Pacemaker
  • Triple Chamber Temporary Pacemaker

Market By Application

  • Arrhythmia
  • Cardiac Perforation
  • Local Trauma
  • Others

Market By End-Use Industry

  • Healthcare
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary